The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II single arm multi-center trial evaluating the efficacy of pembrolizumab in the treatment of patients (pts) with incurable platinum refractory germ cell tumors (GCT).
 
Nabil Adra
No Relationships to Disclose
 
Natraj Ammakkanavar
No Relationships to Disclose
 
Milan Radovich
No Relationships to Disclose
 
David J. Vaughn
Consulting or Advisory Role - Astellas Pharma; Janssen
 
Costantine Albany
No Relationships to Disclose
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen
Consulting or Advisory Role - Celgene; ZIOPHARM Oncology
 
Nasser H. Hanna
Research Funding - Merck (Inst)